Hyundai Pharmaceutical Co. Ltd. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW40.93 |
Market Cap |
KRW131.7 B |
Shares Outstanding |
32 M |
Public Float |
19.34 M |
Address |
55 Jandari-gil Cheonan SC 31213 Korea, Republic Of |
Employees | - |
Website | http://www.hyundaipharm.co.kr |
Updated | 07/08/2019 |
Hyundai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products, health food drinks and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea. |